In spite of its significantly lower affinity toward MDM4 than toward MDM2, the near absence of MDM2 in a retinoblastoma model with elevated MDM4, resulted in remarkable response when the drug was administered directly to the tumor site (Laurie et al., 2006). The gene discussed is MDM2; the disease is retinoblastoma.